Highly Effective Glutathione Injection for Whitening Skin Glutax 180

Name: Highly Effective Glutathione Injection for Whitening Skin Glutax 180
Brand: Nanjing Top Pharma Imp. & Exp. Co., Ltd.
SKU: 2315394395

Jiangsu, ChinaNanjing Top Pharma Imp. & Exp. Co., Ltd.

US$0.10

100 Pieces

Product profile

Customization

Available

Active Ingredient

Reduced L Glutathione, Plant Stem Cell Extracts

Function

Skin Brightening, Antioxidant, Anti Aging

Model NO.

GLUTAX 1800000GS

Key Additive

Alpha Lipoic Acid, Coenzyme Q10, Vitamin C Complex

Feature

Multi Compound Formula

Effect

Improve Dull Complexion, Reduce Skin Pigmentation

Contains

Collagen Peptides, Pdrn DNA Components

Application

Skin Rejuvenation Care

Packaging

Complete Golden Box Set

Storage

Cool Dry Place, Avoid Direct Sunlight

Transport Package

Carton

Specification

GLUTAX 1800000GS

Trademark

OEM

Origin

Italy

Company profile

Importers and ExportersHigh Repeat Buyers Choice

Nanjing Top Pharma Imp. & Exp. Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory, Trading CompanyExport Year: 2017-03-07Nearest Port: Shanghai Port, Qingdao Port, Tianjin PortAverage Response Time: ≤2.39hTerms of Payment: T/TInternational Commercial Terms(Incoterms): FOB, CIF

AI-Powered supplier vetting

SummaryThe supplier operates in textile sales, textile raw-material wholesale, and related technical services, rather than as a professional technical supplier. It supports sample-based and fully customized products, but reports no new products in the past year, one R&D engineer, no ODM, no SDK, and no 3D software design service. Production information identifies ivermectin injection output of 1,000,000 pieces annually, with 6–10 quality-control staff and stated lead times of one month off-season and 2–3 months peak season. Export markets include the Middle East, Southeast Asia, and Africa, while no overseas warehouse, showroom, agent, branch, or overseas service presence is reported. Traceability, quality assurance, environmental assessment, and fire-drill status are unknown. Financial records are identified for 2020–2022, but their results are not provided.

Supplier typeThe supplier is explicitly described as not being a professional technical supplier. Its stated business scope covers needle textile sales, knitted textile and raw-material wholesale, and technical services, development, consultation, exchange, and transfer.

R&D capabilityInnovation evidence is weak: the supplier reports no new products in the past year, has one R&D engineer, provides no ODM service, no SDK, and no 3D software design service. The engineer does support customer-request confirmation, new-product design, and technical production support, but this does not offset the explicitly limited innovation capabilities.

Production capacityThe supplier reports annual ivermectin injection output of 1,000,000 pieces and 6–10 quality-control staff, with stated one-month off-season and 2–3-month peak-season fulfillment times. It also serves export markets in the Middle East, Southeast Asia, and Africa, although another lead-time entry is inconsistent and no broader capacity detail is provided.

Customization capabilityThe supplier explicitly offers customization from samples and full customization. Its technology engineer is responsible for confirming customer requests and designing new products, supporting a demonstrated customization capability despite the limited R&D team.